VNRX Shariah Compliance

Screening Methodology: AAOIFI

lock image
LOCKED

Analyst's Ratings

Based on 10 analysts giving stock ratings to VolitionRX Ltd in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
20
Buy
60
Hold
20
Sell
0
Strong Sell
0
VolitionRX Ltd

VolitionRX Ltd. Stock Analysis VNRX

United States Health Care Micro Cap
VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. The company is headquartered in Henderson, Nevada and currently employs 110 full-time employees. The company went IPO on 2015-02-06. The firm is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.
Read More

VNRX Chart

United States Health Care Micro Cap

VolitionRX Ltd vs S&P 500 Comparative Returns

Analysis of VNRX stock performance compared to the broader market (S&P 500) across multiple timeframes.

YTD Performance
  • VolitionRX Ltd... (VNR...) -14.49%
  • S&P 500 -4.27%
VolitionRX Ltd Underperformed S&P 500 by 10.22%
1Y Performance
  • VolitionRX Ltd... (VNR...) -29.69%
  • S&P 500 8.86%
VolitionRX Ltd Underperformed S&P 500 by 38.55%
3Y Performance
  • VolitionRX Ltd... (VNR...) -79.3%
  • S&P 500 37.21%
VolitionRX Ltd Underperformed S&P 500 by 116.51%
5Y Performance
  • VolitionRX Ltd... (VNR...) -87.56%
  • S&P 500 92.3%
VolitionRX Ltd Underperformed S&P 500 by 179.86%

Key Statistics

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.49$0.52

Today's Open

$0.52

Volume

89.58K

P/E Ratio (TTM)

-

52 Week Range

$0.42$1.02

Market Cap

52.59M

Avg. Volume

283.38K

Dividend Yield

-

Financial Metrics & Statements

  • Per Share Data
  • Ratios
  • Statements
Currency: USD20202021202220232024
Revenue per Share (TTM)
0 0 0.01 0.01 -
EBIT per Share (TTM)
-0.44 -0.53 -0.55 -0.44 -
EPS Forward
-0.45 -0.51 -0.55 -0.5 -

FAQ's

Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.